Deleted Definition Highly Significant for Claim Construction
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by: Brian C. Barnes and Brandon G. Smith
DDR HOLDINGS, LLC V. PRICELINE.COM LLC, BOOKING.COM B.V.
Before Chen, Mayer, and Cunningham.
Appeal from the United States District Court for the Northern District of Delaware.
Summary: Deleting a definition provided in provisional application from the final specification evidenced patentee’s intent to exclude deleted language from claim scope.
DDR Holdings, LLC (“DDR”) sued Priceline.com LLC and Booking.com B.V. (collectively, “Priceline”) for infringement of a patent relating to a composite web page that displays visual elements of a host website with content from a third party “merchant.” Priceline argued it did not infringe because the claim term “merchant” was limited to purveyors of goods alone and did not encompass purveyors of services. DDR argued that “merchant” encompassed purveyors of goods and services based on a definition provided in the provisional application to which the asserted patent claimed priority. However, the patentee deleted that definition from the final specification, which contained no reference merchant services. The district court agreed with Priceline and construed “merchant” to be limited to purveyors of goods.
The Federal Circuit affirmed, holding that the patentee’s deletion of language between the provisional application and the asserted patent’s specification was “highly significant” to its claim construction analysis. The court rejected DDR’s argument that the definition from the provisional should apply because the provisional is incorporated by reference in the asserted patent. The Federal Circuit found that deleting the definition referencing “services” showed “an evolution of the applicant’s intended meaning” of “merchants.”
Editor: Sean Murray
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…